MOG and myeloid sarcoma: The primary aim of the study was to describe the population of MOG antibody seropositive patients at the UBC MS/NMO referral clinic, both clinically and radiologically, with comparison to other published MOG antibody-associated disease cohorts, as well as to the rest of our “NMO-suspects” AQP4 negative cohort.